But we don't need to E and E anymore (well just a little bit to fine tune the little amounts)
because they felt the existing resource alone was enough to start conversations, I believe he wouldn't have said that unless he was confident. The feedback I heard was one shareholder was very adamant on that question in particular Chris said that CR will not be an issue this year let alone next and that there are other options at hand before they have to resort to it.
but as with the growing pessimism, time will tell but until then it's just waiting
- Forums
- ASX - By Stock
- FFX
- Re-Rating: General Lithium & Mali Lithium
Re-Rating: General Lithium & Mali Lithium, page-52
-
- There are more pages in this discussion • 195 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online